肝硬化腹水治疗的新进展_陈煜.pdf
文本预览下载声明
陈煜,等. 肝硬化腹水治疗的新进展 9601
专家论坛
肝硬化腹水治疗的新进展
陈 煜,周 莉
( 首都医科大学附属北京佑安医院 人工肝中心,北京 100069 )
摘要: 腹水是肝硬化最常见并发症之一,预防和控制腹水的发生和发展是改善肝硬化患者预后的关键。就近几年腹水治疗的
新进展进行总结与讨论,主要包括病因治疗、限钠摄入、利尿剂治疗等一线治疗方法的更新,以及对于顽固性腹水治疗的新探索。
关键词: 肝硬化; 腹水; 治疗
中图分类号: R575. 2 文献标志码: A 文章编号: 1001 - 5256( 2016) 06 - 1069 - 06
Research advances in treatment of cirrhotic ascites
, ( , , , ,
CHEN Yu ZHOU Li. Artificial Liver Treatment & Training Center Beijing YouAn Hospital Capital Medical University Beijing 100069
)
China
: ,
Abstract Ascites is the most common complication of liver cirrhosis and prevention and control of the development and progression of asci-
tes are the key to improving the prognosis of patients with liver cirrhosis. This article summarizes the new advances in the treatment of asci-
, , , ,
tes including the update on first - line therapeutic methods such as etiological treatment limited intake of sodium and diuretic treatment
and investigates the treatment of intractable ascites.
: ; ;
Key words liver cirrhosis ascites therapy
[]
, , 3 ;
腹水是肝硬化的主要并发症之一 也是肝硬化患 症如腹水、肝肾综合征等 最终提高患者生存率 同
者住院的主要原因。肝硬化患者
显示全部